NCT05131763 2021-11-23NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid TumorsFudan UniversityPhase 1 Unknown3 enrolled
NCT03941626 2021-02-04Autologous CAR-T/TCR-T Cell Immunotherapy for Solid MalignanciesShenzhen BinDeBio Ltd.Phase 1/2 Unknown50 enrolled
NCT04550663 2020-09-23NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ TumorsThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 1 Unknown10 enrolled
NCT03638206 2019-12-11Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesShenzhen BinDeBio Ltd.Phase 1/2 Unknown73 enrolled